1. Antonini A, Odin P, Kleinman L, Skalicky A, Marshall T, Sail K, Onuk K (2015) Implementing a Delphi panel to improve understanding of patient characteristics of advanced Parkinson’s disease. Mov Disord (Abstract) Presented at the 19th International Congress of Parkinson’s Disease and Movement Disorders. San Diego, CA, USA. Poster 1186
2. Antonini A, Schmidt P, Odin P, Kleinman L, Skalicky A, Sail K, Jalundhwala Y, Zamudio J, Onuk K, Fernandez H (2017). Development of a clinician-reported screening tool to identify patients with Parkinson’s disease inadequately controlled on oral medication. In: Presented at the 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada. Mov Disord (Abstract) 32 (suppl 2): Poster 210
3. Bhidayasiri R, Martinez-Martin P (2017) Clinical assessments in Parkinson’s disease: scales and monitoring. Int Rev Neurobiol 132:129–182. doi:
10.1016/bs.irn.2017.01.001
4. Cersosimo MG, Benarroch EE (2012) Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease. Neurobiol Dis 46(3):559–564. doi:
10.1016/j.nbd.2011.10.014
5. Chahine LM, Weintraub D, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D, Investigators PARS (2016) Cognition in individuals at risk for Parkinson’s: Parkinson associated risk syndrome (PARS) study findings. Mov Disord 31(1):86–94. doi:
10.1002/mds.26373